Skip to main content
. 2018 Oct 16;37:252. doi: 10.1186/s13046-018-0927-8

Fig. 6.

Fig. 6

The expression levels and clinical significance of miRNA-302a/d and E2F7 in HCC. a, qRT-PCR to quantify miRNA-302a/d and E2F7 level in 154 HCC tissues and 34 adjacently normal liver tissues. The correlation between miRNA-302a/d and E2F7 levels in 34 adjacently normal liver tissues (b) and 154 HCC tissues (c). d, qRT-PCR to quantify miRNA-302a/d and E2F7 level in CD133EpCAM HCCs and CD133+EpCAM+ LCSCs from 16 HCC tissues. e, The correlation between miRNA-302a/d and E2F7 levels in CD133EpCAM HCCs and CD133+EpCAM+ LCSCs from 16 HCC tissues. f, Kaplan-Meier survival analysis to evaluate the prognostic value of miRNA-302a, miRNA-302d and E2F7 expression for OS and PFS of HCC patients. Kaplan-Meier survival analysis was used to evaluate the prognostic value of E2F7 together with miRNA-302a (g) or miRNA-302d (h) expression in HCC for OS and PFS